Results 281 to 290 of about 7,856,482 (335)

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source

PCD Receives Highest 5-Year Journal Impact Factor in Its History: Celebrating and Building on 20 Years of Success With Release of 6 Collections in 2025. [PDF]

Prev Chronic Dis
Jack L.
europepmc   +1 more source

The Momentous 2023: Publication Frequency, Impact Factor, and IJPS Archival.

Indian J Plast Surg, 2023
Kadam D.
europepmc   +1 more source

Impact of Environmental & Psychological Factors on Driver’s Behavior and its Respective Effective Measures to be Taken in Terms of Improving Roadway Design and Policymaking [PDF]

Sumbul Mujeeb, Mir Shabbar Ali, Syeda Shahida Batool, Mahnoor Mujeeb, Muhammad Ali Qureshi, Masroor Ali Qureshi   +5 more
openalex   +1 more source

Class IIa HDACs forced degradation allows resensitization of oxaliplatin‐resistant FBXW7‐mutated colorectal cancer

Molecular Oncology, EarlyView.
HDAC4 is degraded by the E3 ligase FBXW7. In colorectal cancer, FBXW7 mutations prevent HDAC4 degradation, leading to oxaliplatin resistance. Forced degradation of HDAC4 using a PROTAC compound restores drug sensitivity by resetting the super‐enhancer landscape, reprogramming the epigenetic state of FBXW7‐mutated cells to resemble oxaliplatin ...
Vanessa Tolotto, Nicolò Gualandi, Ylenia Cortolezzis, Raffaella Picco, Monica Colitti, Francesca D'Este, Mariachiara Gani, Wayne W. Hancock, Giovanni Terrosu, Cristina Degrassi, Francesca Agostini, Claudio Brancolini, Luigi E. Xodo, Eros Di Giorgio   +13 more
wiley   +1 more source

Editor's Note on Recent Journal Impact Factor of Cancer Research and Treatment. [PDF]

Cancer Res Treat
Ahn YC.
europepmc   +1 more source

Journal Impact Factor for the Indian Journal of Plastic Surgery.

Indian J Plast Surg, 2023
Kadam D.
europepmc   +1 more source

Impact Factor [PDF]

Deutsches Ärzteblatt international, 2012
openaire   +1 more source

In vitro models of cancer‐associated fibroblast heterogeneity uncover subtype‐specific effects of CRISPR perturbations

Molecular Oncology, EarlyView.
Development of therapies targeting cancer‐associated fibroblasts (CAFs) necessitates preclinical model systems that faithfully represent CAF–tumor biology. We established an in vitro coculture system of patient‐derived pancreatic CAFs and tumor cell lines and demonstrated its recapitulation of primary CAF–tumor biology with single‐cell transcriptomics ...
Elysia Saputra, Shamsudheen Karuthedath Vellarikkal, Lixia Li, Hong Sun, Khoa Nguyen, Amber Montano, Suchitra Natarajan, Federica Piccioni, Alex Michael Tamburino, Xin Yu, Aleksandra Katarzyna Olow   +10 more
wiley   +1 more source

2023 Journal Citation Report impact factor update and achievements for the Journal of Periodontal & Implant Science. [PDF]

J Periodontal Implant Sci
Park JB, Park SY, Park JC, Kim YG, Ahn HT, Shin SY.   +5 more
europepmc   +1 more source